InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

Current share price for FRE : $0.033 0.001 (3.13%)+

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Firebrick Appoints Rick Legleiter as Director 28 Jul 2025 8:25AM $0.077 $0.033 fallen by 57.14%
$9 June 2025 Quarterly Activity Report & Appendix 4C 23 Jul 2025 8:14AM $0.064 $0.033 fallen by 48.44%
$9 Notification regarding unquoted securities - FRE 4 Jul 2025 5:50PM $0.063 $0.033 fallen by 47.62%
$9 Cleansing Notice 4 Jul 2025 5:37PM $0.063 $0.033 fallen by 47.62%
$9 Application for quotation of securities - FRE 4 Jul 2025 5:33PM $0.063 $0.033 fallen by 47.62%
$9 Proposed issue of securities - FRE 26 Jun 2025 9:08AM $0.070 $0.033 fallen by 52.86%
$9 Firebrick Closes Placement at $0.2 milliion 26 Jun 2025 9:08AM $0.070 $0.033 fallen by 52.86%
$9 Trading Halt 24 Jun 2025 9:03AM $0.070 $0.033 fallen by 52.86%
$9 Firebrick Pharma Investor Presentation 23 June 2025 23 Jun 2025 3:06PM $0.072 $0.033 fallen by 54.17%
$9 Nasodine Phase 3 Common Cold Trial Published 10 Jun 2025 8:38AM $0.067 $0.033 fallen by 50.75%
$9 Withdrawal of Share Placement 6 Jun 2025 4:58PM $0.067 $0.033 fallen by 50.75%
$9 Trading Halt 5 Jun 2025 9:09AM $0.067 $0.033 fallen by 50.75%
$9 March 2025 Quarterly Activity Report & Appendix 4C 16 Apr 2025 10:56AM $0.080 $0.033 fallen by 58.75%
$9 Cleansing Notice 28 Mar 2025 2:58PM $0.091 $0.033 fallen by 63.74%
$9 Application for quotation of securities - FRE 28 Mar 2025 2:56PM $0.091 $0.033 fallen by 63.74%
$9 Cleansing Notice 21 Mar 2025 3:33PM $0.093 $0.033 fallen by 64.52%
$9 Application for quotation of securities - FRE 21 Mar 2025 3:32PM $0.093 $0.033 fallen by 64.52%
$9 Becoming a substantial holder - Pharma Nutria NA Inc 6 Mar 2025 12:02PM $0.094 $0.033 fallen by 64.89%
$9 Becoming a substantial holder - Firebrick Pharma 6 Mar 2025 10:08AM $0.092 $0.033 fallen by 64.13%
$9 Change in substantial holding - Stephen Goodall 6 Mar 2025 10:07AM $0.092 $0.033 fallen by 64.13%
$9 Change in substantial holding - Peter Molloy 6 Mar 2025 10:06AM $0.092 $0.033 fallen by 64.13%
$9 Cleansing Notice 5 Mar 2025 11:06AM $0.092 $0.033 fallen by 64.13%
$9 Application for quotation of securities - FRE 5 Mar 2025 11:04AM $0.092 $0.033 fallen by 64.13%
$9 Proposed issue of securities - FRE 4 Mar 2025 9:12AM $0.090 $0.033 fallen by 63.33%
$9 FRE secures Strategic Investment from Philippines Partner 4 Mar 2025 9:11AM $0.090 $0.033 fallen by 63.33%

101 - 125 of 507 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.